0 CHECKOUT

Acadia Pharmaceuticals Inc. (ACAD) - Financial and Strategic SWOT Analysis Review

  • ID: 1322588
  • July 2016
  • 51 pages
  • GlobalData
1 of 4

Acadia Pharmaceuticals Inc. (ACAD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees READ MORE >

Note: Product cover images may vary from those shown
2 of 4

List of Tables

List of Figures

Section 1 - About the Company

Acadia Pharmaceuticals Inc. - Key Facts

Acadia Pharmaceuticals Inc. - Key Employees

Acadia Pharmaceuticals Inc. - Key Employee Biographies

Acadia Pharmaceuticals Inc. - Major Products and Services

Acadia Pharmaceuticals Inc. - Pharmaceutical Pipeline Products Data

Acadia Pharmaceuticals Inc., Pipeline Products by Therapy Area

Acadia Pharmaceuticals Inc., Pipeline Products by Development Phase

Acadia Pharmaceuticals Inc. - History

Acadia Pharmaceuticals Inc. - Company Statement

Acadia Pharmaceuticals Inc. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Acadia Pharmaceuticals Inc. - Business Description

Acadia Pharmaceuticals Inc. - Corporate Strategy

Acadia Pharmaceuticals Inc. - SWOT Analysis

SWOT Analysis - Overview

Acadia Pharmaceuticals Inc. - Strengths

Strength - Focused Research and Development

Strength - Lead Product: Nuplazid

Strength - Strong Patent Portfolio

Acadia Pharmaceuticals Inc. - Weaknesses

Weakness - Lack of Marketed Products

Acadia Pharmaceuticals Inc. - Opportunities

Opportunity - Market Potential: Parkinson’s Disease

Opportunity - Strong Product Pipeline

Opportunity - Changing Demographics

Acadia Pharmaceuticals Inc. - Threats

Threat - Intense Competition

Threat - Uncertain R&D Outcomes

Threat - Lack of Manufacturing Facilities

Threat - Stringent Government Regulations

Acadia Pharmaceuticals Inc. - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016

Acadia Pharmaceuticals Inc., Recent Deals Summary

Section 5 – Company’s Recent Developments

May 05, 2016: ACADIA Pharmaceuticals Reports First Quarter 2016 Financial Results

Feb 29, 2016: ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2015

Jan 25, 2016: ACADIA Pharmaceuticals Appoints James R. Owen, M.D., as Senior Vice President, Clinical Development and Chief Medical Officer

Jan 11, 2016: ACADIA Pharmaceuticals Appoints Jim Daly to Board of Directors

Dec 15, 2015: ACADIA Pharmaceuticals Appoints Julian C. Baker to Board of Directors

Nov 30, 2015: ACADIA Pharmaceuticals Appoints Srdjan Stankovic, M.D., M.S.P.H., as Executive Vice President, Head of Research and Development

Nov 30, 2015: ACADIA Pharmaceuticals Appoints Edmund P. Harrigan, M.D., to Board of Directors

Nov 05, 2015: ACADIA Pharmaceuticals Reports Third Quarter 2015 Financial Results

Sep 03, 2015: ACADIA Pharmaceuticals Appoints Steve Davis as Chief Executive Officer

Aug 06, 2015: ACADIA Pharmaceuticals Reports Second Quarter 2015 Financial Results

Section 6 – Appendix

Methodology

Ratio Definitions

About us

Contact Us

Disclaimer

List of Tables

Acadia Pharmaceuticals Inc., Key Facts

Acadia Pharmaceuticals Inc., Key Employees

Acadia Pharmaceuticals Inc., Key Employee Biographies

Acadia Pharmaceuticals Inc., Major Products and Services

Acadia Pharmaceuticals Inc., Number of Pipeline Products by Therapy Area

Acadia Pharmaceuticals Inc., Number of Pipeline Products by Development Stage

Acadia Pharmaceuticals Inc., Pipeline Products By Therapy Area and Development Phase

Acadia Pharmaceuticals Inc., History

Acadia Pharmaceuticals Inc., Subsidiaries

Acadia Pharmaceuticals Inc., Key Competitors

Acadia Pharmaceuticals Inc., Ratios based on current share price

Acadia Pharmaceuticals Inc., Annual Ratios

Acadia Pharmaceuticals Inc., Interim Ratios

Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016

Acadia Pharmaceuticals Inc., Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

Acadia Pharmaceuticals Inc., Pipeline Products by Therapy Area

Acadia Pharmaceuticals Inc., Pipeline Products by Development Phase

Acadia Pharmaceuticals Inc., Performance Chart (2011 - 2015)

Acadia Pharmaceuticals Inc., Ratio Charts

Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Note: Product cover images may vary from those shown
3 of 4

Pfizer AB
Novartis Pharmaceuticals Corporation
Cytogel Pharma, LLC

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.